Table 2.
Multidrug resistance profile of Salmonella used in this study.
| Isolates | No. of Antibiotic (Class) | Multidrug Profile | No. of Isolates (%) | Prevalence of MDR % |
|---|---|---|---|---|
|
Salmonella (n = 35) |
1 (1) | Any one of the tested antibiotics | 0 | 100 |
| 2 (2) | TE-AMP or other combination of two antibiotic classes | 0 | ||
| 3 (3) | TE-AMP-C | 28 (80) | ||
| TE-S-C | 26 (74.28) | |||
| 4 (4) | C-AMP-S-TE | 24 (68.57) | ||
| CIP-AMP-TE-S | 5 (14.28) | |||
| 5 (5) | C-AMP-S-TE-CIP | 1 (2.87) | ||
| C-AMP-S-TE-ETP | 1 (2.87) |
Note: TE, tetracycline; AMP, ampicillin; C, chloramphenicol; S, streptomycin; CIP, ciprofloxacin; ETP, ertapenem; MDR, multidrug resistance.